Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
ClinicoEconomics and Outcomes Research
ISSN: 1178-6981
- View all (812)
- Volume 15, 2023 (32)
- Volume 14, 2022 (61)
- Volume 13, 2021 (90)
- Volume 12, 2020 (70)
- Volume 11, 2019 (71)
- Volume 10, 2018 (77)
- Volume 9, 2017 (77)
- Volume 8, 2016 (73)
- Volume 7, 2015 (64)
- Volume 6, 2014 (53)
- Volume 5, 2013 (59)
- Volume 4, 2012 (41)
- Volume 3, 2011 (19)
- Volume 2, 2010 (16)
- Volume 1, 2009 (9)
Archive: Volume 10, 2018
- default (77)
- Health-related Outcomes and Economic Burden in Japan. Focus on: Inflammatory Bowel Disease, Multiple Sclerosis, and Depression (4)
The number needed to treat and relevant between-trial comparisons of competing interventions
Jansen JP, Khalid JM, Smyth MD, Patel H
ClinicoEconomics and Outcomes Research 2018, 10:865-871
Published Date: 14 December 2018
The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings
Fitch K, Lau J, Engel T, Medicis JJ, Mohr JF, Weintraub WS
ClinicoEconomics and Outcomes Research 2018, 10:855-863
Published Date: 14 December 2018
A methodological review of national and transnational pharmaceutical budget impact analysis guidelines for new drug submissions
Foroutan N, Tarride JE, Xie F, Levine M
ClinicoEconomics and Outcomes Research 2018, 10:821-854
Published Date: 26 November 2018
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies
Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
ClinicoEconomics and Outcomes Research 2018, 10:805-819
Published Date: 16 November 2018
Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective
Shah D, Risebrough NA, Perdrizet J, Iyer NN, Gamble C, Dang-Tan T
ClinicoEconomics and Outcomes Research 2018, 10:791-803
Published Date: 14 November 2018
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain
Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A
ClinicoEconomics and Outcomes Research 2018, 10:773-790
Published Date: 14 November 2018
Impact of postcolectomy adhesion-related complications on healthcare utilization
Etter K, Sutton N, Wei D, Yoo A
ClinicoEconomics and Outcomes Research 2018, 10:761-771
Published Date: 14 November 2018
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S
ClinicoEconomics and Outcomes Research 2018, 10:747-759
Published Date: 12 November 2018
Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk
Povero M, Miceli A, Pradelli L, Ferrarini M, Pinciroli M, Glauber M
ClinicoEconomics and Outcomes Research 2018, 10:733-745
Published Date: 8 November 2018
Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region [Corrigendum]
Cammarota S, Citarella A, Manzoli L, Flacco ME, Parruti G
ClinicoEconomics and Outcomes Research 2018, 10:731-732
Published Date: 8 November 2018
Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferon
Chen C, Wu N, Watson C
ClinicoEconomics and Outcomes Research 2018, 10:723-730
Published Date: 2 November 2018
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
Tremblay G, Dolph M, Bhor M, Said Q, Roy A, Elliott B, Briggs A
ClinicoEconomics and Outcomes Research 2018, 10:715-721
Published Date: 5 November 2018
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
Tremblay G, Dolph M, Bhor M, Said Q, Elliott B, Briggs A
ClinicoEconomics and Outcomes Research 2018, 10:705-713
Published Date: 1 November 2018
Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease
Iyer NN, Vendetti NJ, Levy DI, Mardekian J, Mychaskiw MA, Thomas III J
ClinicoEconomics and Outcomes Research 2018, 10:693-703
Published Date: 31 October 2018
Burden of cancer pain in developing countries: a narrative literature review
Li Z, Aninditha T, Griene B, Francis J, Renato P, Serrie A, Umareddy I, Boisseau S, Hadjiat Y
ClinicoEconomics and Outcomes Research 2018, 10:675-691
Published Date: 2 November 2018
Economic benefits of implementing patient-centered medical home among patients with hypertension
Almalki ZS, Alotaibi AA, Alzaidi WS, Alghamdi AA, Bahowirth AM, Alsalamah NM
ClinicoEconomics and Outcomes Research 2018, 10:665-673
Published Date: 31 October 2018
Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada
O'Reilly DJ, Blackhouse G, Burns S, Bowen JM, Burke N, Mehltretter J, Waite NM, Houle SKD
ClinicoEconomics and Outcomes Research 2018, 10:655-663
Published Date: 24 October 2018
Health-related outcomes and economic burden in Japan: focus on inflammatory bowel disease, multiple sclerosis, and depression
Yamabe K
ClinicoEconomics and Outcomes Research 2018, 10:653-654
Published Date: 23 October 2018
Sacroiliac joint fusion health care cost comparison prior to and following surgery: an administrative claims analysis
Buysman EK, Halpern R, Polly DW
ClinicoEconomics and Outcomes Research 2018, 10:643-651
Published Date: 17 October 2018
Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure
Bonafede M, Feliciano J, Cai Q, Noxon V, Princic N, Richhariya A, Straus DJ
ClinicoEconomics and Outcomes Research 2018, 10:629-641
Published Date: 17 October 2018
Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs
Rajagopalan K, Candrilli SD, Ajmera M
ClinicoEconomics and Outcomes Research 2018, 10:619-627
Published Date: 16 October 2018
The role of a best practice alert in the electronic medical record in reducing repetitive lab tests
Bejjanki H, Mramba LK, Beal SG, Radhakrishnan N, Bishnoi R, Shah C, Agrawal N, Harris N, Leverence R, Rand K
ClinicoEconomics and Outcomes Research 2018, 10:611-618
Published Date: 8 October 2018
A single blind, multicenter, randomized controlled trial to evaluate the effectiveness and cost of a novel nutraceutical (LopiGLIK®) lowering cardiovascular disease risk
Manfrin A, Trimarco V, Manzi MV, Rozza F, Izzo R
ClinicoEconomics and Outcomes Research 2018, 10:601-609
Published Date: 8 October 2018
Comparison of real-world clinical and economic outcomes between the ThermoCool® SF and ThermoCool® catheters in patients undergoing radiofrequency catheter ablation for atrial fibrillation
Chinitz L, Goldstein LJ, Barnow A, Maccioni S, Daskiran M, Kalsekar I, Khanna R
ClinicoEconomics and Outcomes Research 2018, 10:587-599
Published Date: 4 October 2018
Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
Shafrin J, Bognar K, Everson K, Brauer M, Lakdawalla DN, Forma FM
ClinicoEconomics and Outcomes Research 2018, 10:573-585
Published Date: 2 October 2018
Societal costs due to meningococcal disease: a national registry-based study
Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Østergaard L
ClinicoEconomics and Outcomes Research 2018, 10:563-572
Published Date: 2 October 2018
Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost
Maeng DD, Graham J, Bogart M, Hao J, Wright EA
ClinicoEconomics and Outcomes Research 2018, 10:551-562
Published Date: 24 September 2018
Cost-effectiveness analysis of treatment timing considering the future entry of lower-cost generics for hepatitis C
Heath K
ClinicoEconomics and Outcomes Research 2018, 10:539-550
Published Date: 20 September 2018
Cost of acute cough in Italian children
Dal Negro RW, Turco P, Povero M
ClinicoEconomics and Outcomes Research 2018, 10:529-537
Published Date: 17 September 2018
Propensity score matching comparison of laparoscopic versus open surgery for rectal cancer in a middle-income country: short-term outcomes and cost analysis
Tayar DO, Ribeiro Jr U, Cecconello I, Magalhães TM, Simões CM, Auler Jr JOC
ClinicoEconomics and Outcomes Research 2018, 10:521-527
Published Date: 12 September 2018
Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico
Morfín-Otero R, Alvarado-Ibarra M, Rodriguez-Noriega E, Resendiz-Sanchez J, Patel DA, Stephens JM, Di Fusco M, Mendoza CF, Charbonneau C
ClinicoEconomics and Outcomes Research 2018, 10:511-520
Published Date: 6 September 2018
Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS
Vallejo-Aparicio LA, Peces-Barba G, Gil A, Huerta Hernandez A
ClinicoEconomics and Outcomes Research 2018, 10:501-510
Published Date: 5 September 2018
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, Korrer S
ClinicoEconomics and Outcomes Research 2018, 10:493-500
Published Date: 3 September 2018
Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative
Colombo GL, Di Matteo S, Martinotti C, Jugl SM, Gunda P, Naclerio M, Bruno GM
ClinicoEconomics and Outcomes Research 2018, 10:477-491
Published Date: 30 August 2018
Obesity in Germany and Italy: prevalence, comorbidities, and associations with patient outcomes
DiBonaventura M, Nicolucci A, Meincke H, Le Lay A, Fournier J
ClinicoEconomics and Outcomes Research 2018, 10:457-475
Published Date: 24 August 2018
Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
Aigbogun MS, Liu S, Kamat SA, Sapin C, Duhig AM, Citrome L
ClinicoEconomics and Outcomes Research 2018, 10:443-456
Published Date: 16 August 2018
Cost of opioid medication abuse with and without tampering in the USA
Vietri J, Masters ET, Barsdorf AI, Mardekian J
ClinicoEconomics and Outcomes Research 2018, 10:433-442
Published Date: 10 August 2018
The burden of cystic fibrosis in the Medicaid population
Hassan M, Bonafede MM, Limone BL, Hodgkins P, Sawicki GS
ClinicoEconomics and Outcomes Research 2018, 10:423-431
Published Date: 25 July 2018
Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes
Torre E, Bruno GM, Di Matteo S, Martinotti C, Oselin M, Valentino MC, Parodi A, Bottaro LC, Colombo GL
ClinicoEconomics and Outcomes Research 2018, 10:413-421
Published Date: 26 July 2018
Procedure costs associated with the use of Harmonic devices compared to conventional techniques in various surgeries: a systematic review and meta-analysis
Cheng H, Clymer JW, Qadeer RA, Ferko N, Sadeghirad B, Cameron CG, Amaral JF
ClinicoEconomics and Outcomes Research 2018, 10:399-412
Published Date: 24 July 2018
Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region
Cammarota S, Citarella A, Manzoli L, Flacco ME, Parruti G
ClinicoEconomics and Outcomes Research 2018, 10:389-398
Published Date: 23 July 2018
Health-care utilization and outcomes of patients at high risk of invasive fungal infection
Fu R, Gundrum J, Sung AH
ClinicoEconomics and Outcomes Research 2018, 10:371-387
Published Date: 12 July 2018
A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective
Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P
ClinicoEconomics and Outcomes Research 2018, 10:359-370
Published Date: 16 July 2018
Post-lumbar discectomy reoperations that are associated with poor clinical and socioeconomic outcomes can be reduced through use of a novel annular closure device: results from a 2-year randomized controlled trial
Klassen PD, Hsu WK, Martens F, Inzana JA, van den Brink WA, Groff MW, Thomé C
ClinicoEconomics and Outcomes Research 2018, 10:349-357
Published Date: 26 June 2018
Evaluation of statin utilization in the Republic of Macedonia during 2013–2016
Naumovska Z, Nestorovska AK, Grozdanova A, Hristova K, Dimovski A, Suturkova L, Sterjev Z
ClinicoEconomics and Outcomes Research 2018, 10:339-347
Published Date: 26 June 2018
Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia
Qerimi V, Kapedanovska Nestorovska A, Sterjev Z, Genadieva-Stavric S, Suturkova L
ClinicoEconomics and Outcomes Research 2018, 10:327-338
Published Date: 20 June 2018
The cost of dysphagia in geriatric patients
Westmark S, Melgaard D, Rethmeier LO, Ehlers LH
ClinicoEconomics and Outcomes Research 2018, 10:321-326
Published Date: 6 June 2018
A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States
Zhang W, Amos TB, Gutkin SW, Lodowski N, Giegerich E, Joshi K
ClinicoEconomics and Outcomes Research 2018, 10:309-320
Published Date: 8 June 2018
A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?
Galli T, Mirata P, Foglia E, Croce D, Porazzi E, Ferrario L, Ricci E, Garagiola E, Pagani R, Banfi G
ClinicoEconomics and Outcomes Research 2018, 10:301-307
Published Date: 5 June 2018
Early introduction of a semi-elemental formula may be cost saving compared to a polymeric formula among critically ill patients requiring enteral nutrition: a cohort cost–consequence model
Curry AS, Chadda S, Danel A, Nguyen DL
ClinicoEconomics and Outcomes Research 2018, 10:293-300
Published Date: 5 June 2018
Cost-effectiveness of pulse-echo ultrasonometry in osteoporosis management
Soini E, Riekkinen O, Kröger H, Mankinen P, Hallinen T, Karjalainen JP
ClinicoEconomics and Outcomes Research 2018, 10:279-292
Published Date: 29 May 2018
Economic evaluation of point-of-care testing in the remote primary health care setting of Australia’s Northern Territory
Spaeth BA, Kaambwa B, Shephard MDS, Omond R
ClinicoEconomics and Outcomes Research 2018, 10:269-277
Published Date: 29 May 2018
Claims-based proxies of patient instability among commercially insured adults with schizophrenia
Ruetsch C, Un H, Waters HC
ClinicoEconomics and Outcomes Research 2018, 10:259-267
Published Date: 7 May 2018
Prevalence of antibiotic prescription in southern Italian outpatients: real-world data analysis of socioeconomic and sociodemographic variables at a municipality level
Russo V, Monetti VM, Guerriero F, Trama U, Guida A, Menditto E, Orlando V
ClinicoEconomics and Outcomes Research 2018, 10:251-258
Published Date: 3 May 2018
Cost-effectiveness comparison of cabozantinib with everolimus, axitinib, and nivolumab in the treatment of advanced renal cell carcinoma following the failure of prior therapy in England
Meng J, Lister J, Vataire AL, Casciano R, Dinet J
ClinicoEconomics and Outcomes Research 2018, 10:243-250
Published Date: 23 April 2018
Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis
Saunders R, Comerota AJ, Ozols A, Torrejon Torres R, Ho KM
ClinicoEconomics and Outcomes Research 2018, 10:231-241
Published Date: 19 April 2018
An evaluation of the budget impact of a new 20% subcutaneous immunoglobulin (Ig20Gly) for the management of primary immunodeficiency diseases in Switzerland
Pollock RF, Meckley LM
ClinicoEconomics and Outcomes Research 2018, 10:223-229
Published Date: 10 April 2018
The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis
Shelbaya A, Solem CT, Walker C, Wan Y, Johnson C, Cappelleri JC
ClinicoEconomics and Outcomes Research 2018, 10:213-222
Published Date: 6 April 2018
Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada
Rattray DD, Weins L, Regush LC, Bowen JM, O'Reilly D, Thiel JA
ClinicoEconomics and Outcomes Research 2018, 10:201-212
Published Date: 5 April 2018
Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals
Martínez del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J
ClinicoEconomics and Outcomes Research 2018, 10:189-199
Published Date: 19 March 2018
Cost analysis of a growth guidance system compared with traditional and magnetically controlled growing rods for early-onset scoliosis: a US-based integrated health care delivery system perspective
Luhmann SJ, McAughey EM, Ackerman SJ, Bumpass DB, McCarthy RE
ClinicoEconomics and Outcomes Research 2018, 10:179-187
Published Date: 16 March 2018
Cost utility, budget impact, and scenario analysis of racecadotril in addition to oral rehydration for acute diarrhea in children in Malaysia
Rautenberg TA, Zerwes U, Lee WS
ClinicoEconomics and Outcomes Research 2018, 10:169-178
Published Date: 15 March 2018
Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography
Vlahiotis A, Griffin B, Stavros AT, Margolis J
ClinicoEconomics and Outcomes Research 2018, 10:157-167
Published Date: 26 March 2018
Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant [Corrigendum]
Droghetti A, Marulli G, Vannucci J, Giovanardi M, Bottoli MC, Ragusa M, Muriana G
ClinicoEconomics and Outcomes Research 2018, 10:155-156
Published Date: 13 March 2018
Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes
Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Tahami Monfared AA, Yuan Y, Juarez-Garcia A, Tyas D, Lees M
ClinicoEconomics and Outcomes Research 2018, 10:139-154
Published Date: 8 March 2018
Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada
Tarride JE, Hopkins RB, Burke N, Guertin JR, O'Reilly D, Fell CD, Dion G, Kolb M
ClinicoEconomics and Outcomes Research 2018, 10:127-137
Published Date: 22 February 2018
Early laparoscopic cholecystectomy is more cost-effective than delayed laparoscopic cholecystectomy in the treatment of acute cholecystitis
Kerwat D, Zargaran A, Bharamgoudar R, Arif N, Bello G, Sharma B, Kerwat R
ClinicoEconomics and Outcomes Research 2018, 10:119-125
Published Date: 19 February 2018
A cost-utility analysis of small bite sutures versus large bite sutures in the closure of midline laparotomies in the United Kingdom National Health Service
Gokani SA, Elmqvist KO, El-Koubani O, Ash J, Biswas SK, Rigaudy M
ClinicoEconomics and Outcomes Research 2018, 10:105-117
Published Date: 19 February 2018
Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis
Stein J, Haas JS, Ong SH, Borchert K, Hardt T, Lechat E, Nip K, Foerster D, Braun S, Baumgart DC
ClinicoEconomics and Outcomes Research 2018, 10:93-103
Published Date: 5 February 2018
Systematic review of health state utility values for acute myeloid leukemia
Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G
ClinicoEconomics and Outcomes Research 2018, 10:83-92
Published Date: 25 January 2018
The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis
Colombo GL, Di Matteo S, Martinotti C, Oselin M, Bruno GM, Beghi GM
ClinicoEconomics and Outcomes Research 2018, 10:75-82
Published Date: 23 January 2018
A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
Baker CL, Pietri G
ClinicoEconomics and Outcomes Research 2018, 10:67-74
Published Date: 19 January 2018
Pain associated with health and economic burden in France: results from recent National Health and Wellness Survey data
Hadjiat Y, Serrie A, Treves R, Chomier B, Geranton L, Billon S
ClinicoEconomics and Outcomes Research 2018, 10:53-65
Published Date: 18 January 2018
Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy
Mennini FS, Viti R, Marcellusi A, Sciattella P, Viapiana O, Rossini M
ClinicoEconomics and Outcomes Research 2018, 10:45-51
Published Date: 10 January 2018
Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
Ulchaker JC, Martinson MS
ClinicoEconomics and Outcomes Research 2018, 10:29-43
Published Date: 29 December 2017
Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer’s disease in Japan
Montgomery W, Ueda K, Jorgensen M, Stathis S, Cheng Y, Nakamura T
ClinicoEconomics and Outcomes Research 2018, 10:13-28
Published Date: 28 December 2017
Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy
Zhu J, Kirkham HS, Ayer G, Chen CC, Wade RL, Karkare SU, Robson CH, Orange JS
ClinicoEconomics and Outcomes Research 2018, 10:1-12
Published Date: 19 December 2017